The role of proto-oncogenes in coronary restenosis

Progress in Cardiovascular Diseases

Volumn 40, Issue 2, 1997, Pages 117-128

  Muller, D W M ^a  

^a ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLIN DEPENDENT KINASE; CYCLINE; DNA BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; RAPAMYCIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ARTERY INJURY; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CORONARY ARTERY DISEASE; GENE TRANSFER; HUMAN; IMMEDIATE EARLY GENE; NONHUMAN; PROTO ONCOGENE; RAT; RESTENOSIS; REVIEW; TUMOR SUPPRESSOR GENE; VASCULAR SMOOTH MUSCLE;

EID: 0030885378     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(97)80004-7     Document Type: Article

References (101)

1. The Bypass Angioplasty Revascularization (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
2. Gruntzig AR Senning A Giegenthaler WE Nonoperative dilation of coronary artery stenosis. Percutaneous transluminal coronary angioplasty N Engl J Med 301 1979 61 68
3. Liu M Roubin G King S Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia Circulation 79 1989 1374 1387
4. Ellis SG Muller DWM Arterial injury and the enigma of coronary restenosis J Am Coll Cardiol 19 1992 275 277
5. Clowes AW Reidy MA Clowes MM Mechanisms of stenosis after arterial injury Lab Invest 49 1983 208 215
6. Lafont A Guzman LA Whitlow PL Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling Circ Res 76 1995 996 1002
7. Post MJ Borst C Kuntz RE The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic yucatan micropig Circulation 89 1994 2816 2821
8. Andersen H Maeng M Thorwest M Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Insights from a porcine coronary (re)stenosis model Circulation 93 1996 1716 1724
9. Mintz GS Popma JJ Pichard AD Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study Circulation 94 1996 35 43
10. Topol EJ Nissen SE Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease Circulation 92 1995 2333 2342
11. Di Mario C Gil R Camenzind E Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy Am J Cardiol 75 1995 772 777
12. Savage M Fischman D Schatz R Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation J Am Coll Cardiol 24 1994 1207 1212
13. Serruys P de Jaegere P Kiemeneij F A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease N Engl J Med 8 1994 489 495
14. Scott NA Cipolla GD Ross CE Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries Circulation 93 1996 2178 2187
15. Clowes AW Reidy MA Clowes MM Kinetics of cellular proliferation after arterial injury. I. Smooth muscle cell growth in the absence of endothelium Lab Invest 49 1983 327 333
16. O'Brien E Alpers C Stewart D Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy Circulation Research 73 1993 223 231
17. Pickering J Weir L Jekanowski J Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization J Clin Invest 91 1993 1469 1480
18. Williams L Signal transduction by the platelet-derived growth factor receptor Science 243 1989 1564 1570
19. Ullrich A Schlessinger J Signal transduction by receptors with tyrosine kinase activity Cell 61 1990 203 212
20. Cantley LC Auger KR Carpenter C Oncogenes and signal transduction Cell 64 1991 281 302
21. Pardee A G1 events and regulation of cell proliferation Science 246 1989 603 608
22. Bravo R Genes induced during the G0/G1 transition in mouse fibroblasts Semin Cancer Biol 1 1990 37 46
23. Miano J Tota R Vlasic N Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal Am J Pathol 137 1990 761 765
24. Bauters C de Groote P Adamantidis M Proto-oncogene expression in rabbit aorta after wall injury. First marker of the cellular process leading to restenosis after angioplasty? Eur Heart J 13 1992 556 559
25. Marmur JD Poon M Rossikhina M Induction of PDGF-responsive genes in vascular smooth muscle: Implications for the early response to vessel injury Circulation 86 suppl III 1992 III
26. Taubman M Rollins B Poon M JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells Circ Res 70 1992 314 325
27. Travali S Ferber A Reiss K Effect of the myb gene product on the expression of the PCNA gene in fibroblasts Oncogene 6 1991 887 894
28. Freeman R Donoghue D Protein kinases and protooncogenes: Biochemical regulators of the eukaryotic cell cycle Biochemistry 30 1991 2293 2302
29. Hartwell L Kastan M Cell cycle control and cancer Science 266 1994 1821 1828
30. Alexandrow M Moses H Transforming growth factor β and cell cycle regulation Cancer Res 55 1995 1452 1457
31. Marx J New tumor suppressor may rival p53 Science 264 1994 344 345
32. Vogelstein B Kinzler K p53 function and dysfunction Cell 70 1992 523 526
33. Antoniades H Galanopoulos T Neville-Golden J p53 expression during normal tissue regeneration in response to acute cutaneous injury in swine J Clin Invest 93 1994 2206 2214
34. Symonds H Krall L Remington L p53-dependent apoptosis suppresses tumor growth and progression in vivo Cell 78 1994 703 711
35. Li R Waga S Hannon GJ Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair Nature 371 1994 534 537
36. Serra R Moses H Tumor suppressor genes in the TGF-β signaling pathway? Nature Medicine 2 1996 390 391
37. Chen PL Scully P Shew JY Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation Cell 58 1989 1193 1198
38. DeCaprio JA Furukawa Y Ajchenbaum F The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression Proc Natl Acad Sci U S A 89 1992 1795 1798
39. Steller H Mechanisms and genes of cellular suicide Science 267 1995 1445 1449
40. Bennett M Evan G The molecular basis of apoptosis Heart Failure 9 1994 199 212
41. Yonish-Rouach E Resnitzky D Lotem J Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 Nature 352 1991 345 347
42. Lowe SW Schmitt EM Smith SW p53 is required for radiation-induced apoptosis in mouse thymocytes Nature 362 1993 847 849
43. Xia Z Dickens M Raingeaud J Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
44. Bennett M Evan G Schwartz S Apoptosis of human vascular smooth muscle cells derived from normal and coronary atherosclerotic plaques J Clin Invest 95 1995 2266 2274
45. Isner J Kearney M Bortman S Apoptosis in human atherosclerosis and restenosis Circulation 91 1995 2703 2711
46. Han DK Haudenschild CC Hong MK Evidence for apoptosis in human atherogenesis and in rat vascular injury model Am J Pathol 147 1995 267 277
47. Bochaton-Piallat M Gabbiani F Redard M Apoptosis participates in cellularity regulation during rat aortic intimal thickening Am J Pathol 146 1995 1059 1064
48. Geng Y Wu Q Muszynsjki M Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta Arterioscler Thromb Vasc Biol 16 1996 19 27
49. Leszczynski D Zhao Y Luokkamaki M Apoptosis of vascular smooth muscle cells. Protein kinase C and oncoprotein Bcl-2 are involved in regulation of apoptosis in non-transformed vascular smooth muscle cells Am J Pathol 145 1994 1265 1270
50. Schwartz S Campbell G Campbell J Replication of smooth muscle cells in vascular disease Circ Res 58 1986 427 444
51. Kocher O Gabbiani F Gabbiani G Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening: Biochemical and morphological studies Lab Invest 65 1991 459 470
52. Weir L Chen D Pastore C Expression of gax, a growth arrest homeobox gene, is rapidly down-regulated in the rat carotid artery during the proliferative response to balloon injury J Biol Chem 270 1995 5457 5461
53. Firulli AB Miano JM Bi W Myocyte enhancer binding factor-2 expression and activity in vascular smooth muscle cells. Association with the activated phenotype Circ Res 78 1996 196 204
54. Andres V Fisher S Wearsch P Regulation of Gax homeobox gene transcription by a combination of positive factors including myocyte-specific enhancer factor 2 Mol Cell Biol 15 1995 4272 4281
55. Simons M Leclerc G Safian R Relation between activated smooth muscle cells in coronary artery lesions and restenosis after atherectomy N Engl J Med 328 1993 608 613
56. Kim D-K Zhang L Dzau V H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury J Clin Invest 93 1994 355 360
57. Inaba T Gotoda T Harada K Induction of sustained expression of proto-oncogene c- fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-γ and macrophage colony-stimulating factor in human aortic smooth muscle cells J Clin Invest 95 1995 1133 1139
58. Ross R Wight T Strandness E Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery Am J Pathol 114 1984 79 93
59. Moss N Benditt E Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics Am J Pathol 114 1973 175 190
60. Smith J Pereira-Smith O Replicative senescence: Implications for in vivo aging and tumor suppression Science 273 1996 63 67
61. Gibbons GH Pratt RE Dzau VJ Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II J Clin Invest 90 1992 456 461
62. Rosales O Sumpio B Changes in cyclic strain increase inositol triphosphate and diacylglycerol in endothelial cells Am J Physiol 262 1992 C956 C962
63. Ranjan V Diamond S Fluid shear stress induces synthesis and nuclear localization of c- fos in cultured human endothelial cells Biochem Biophys Res Commun 196 1993 79 84
64. Mann MJ Gibbons GH Kernoff RS Genetic engineering of vein grafts resistant to atherosclerosis Proc Natl Acad Sci USA 92 1995 4502 4506
65. Benditt E Benditt J Evidence for a monoclonal origin of human atherosclerotic plaques Proc Natl Acad Sci USA 70 1973 1753 1756
66. Thomas WA Kim DN Biology of disease. Atherosclerosis as a hyperplastic and/or neoplastic process Lab Invest 48 1983 245 255
67. Schwartz SM Heimark RL Majesky MW Developmental mechanisms underlying pathology of arteries Physiol Rev 70 1990 1177 1209
68. Speir E Modali R Huang E-S Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science 265 1994 391 394
69. Fabricant CG Fabricant J Litrenta MM Virusinduced atherosclerosis J Exp Med 148 1978 335 340
70. Muganda P Mendoza O Hernandez J Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts J Virol 68 1994 8028 8034
71. Jault F Jault J Rutchi F Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest J Virol 69 1995 6697 6704
72. Bennett M Schwartz S Antisense therapy for angioplasty restenosis. Some critical considerations Circulation 92 1995 1981 1993
73. Simons M Edelman E Dekeyser J-L Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Nature 359 1992 67 70
74. Simons M Rosenberg R Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro Circ Res 70 1992 835 843
75. Villa A Guzman L Poptic E Effects of antisense c- myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury Circ Res 76 1995 505 513
76. Shi Y Fard A Galeo A Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury Circulation 90 1994 944 951
77. Biro S Fu Y-M Yu Z-X Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration Proc Natl Acad Sci USA 90 1993 654 658
78. Bennett M Anglin S McEwan J Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c- myc antisense oligodeoxynucleotides J Clin Invest 93 1994 820 828
79. Shi Y Hutchinson H Hall D Downregulation of c- myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells Circulation 88 1993 1190 1195
80. Speir E Epstein S Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen Circulation 86 1992 538 547
81. Simons M Edelman E Rosenberg R Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model J Clin Invest 93 1994 2351 2356
82. Morishita R Gibbons GH Ellison KE Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proc Natl Acad Sci USA 90 1993 8474 8478
83. Morishita R Gibbons GH Ellison KE Intimal hyperplasia after vascular injury is inhibited by antisense cdk2 kinase oligonucleotides J Clin Invest 93 1994 1458 1464
84. Edelman E Simons M Sirois M c- myc in vasculoproliferative disease Circ Res 76 1995 176 182
85. Bennett C Chiang M Chan H Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides Mol Pharmacol 41 1992 1023 1033
86. Citro G Perrotti D Cucco C Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides Proc Natl Acad Sci USA 89 1992 7031 7035
87. Woolf TM Melton DA Jennings CGB Specificity of antisense oligonucleotides in vivo Proc Natl Acad Sci USA 89 1992 7305 7309
88. Burgess T Fisher E Ross S The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism Proc Natl Acad Sci USA 92 1995 4051 4055
89. Hansson GK Jonasson L Holm J γ-Interferon regulates vascular smooth muscle proliferation and la expression in vivo and in vitro Circ Res 63 1988 712 719
90. Morishita R Gibbons GH Horiuchi M A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle cell proliferation in vivo Proc Natl Acad Sci USA 92 1995 5855 5859
91. Marx SO Jayaraman T Go LO Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells Circ Res 76 1995 412 417
92. Gregory CR Huang X Pratt RE Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement Transplantation 59 1995 655 661
93. Deshane J Siegal GP Alvarez RD Targeted tumor killing via an intracellular antibody against erbB-2 J Clin Invest 96 1995 2980 2989
94. Indolfi C Avvedimento EV Rapacciuolo A Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo Nat Med 1 1995 541 545
95. Gomez-Manzano C Fueyo J Kyritsis AP Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis Cancer Res 56 1996 694 699
96. Yang ZY Perkins ND Ohno T The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo Nat Med 1 1995 1052 1056
97. Craig C Katayose D Wersto R Effects of a recombinant adenovirus vector expressing p27kip1 on cell growth, cell cycle, cyclin kinases and apoptosis (abstr) Proc Annu Meet Am Assoc Cancer Res 37 1996 A13
98. Chang M Barr E Seltzer J Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product Science 267 1995 518 522
99. Chang M Barr E Lu M Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty J Clin Invest 96 1995 2260 2268
100. Yang Z-Y Simari RD Perkins ND Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury Proc Natl Acad Sci USA 93 1996 7905 7910
101. Ohno T Gordon D San H Gene therapy for vascular smooth muscle cell proliferation after arterial injury Science 265 1994 781 784